Save this site as my preferred OppenheimerFunds experience
Save
No, Thanks

Spoof Access

×

Global Equity

The Strategy typically invests opportunistically in both U.S. and foreign stocks.
Cumulative Total Returns

as of 8/31/16

Since Inception 10/22/90
1561%
Performance & Distributions
×

Global Equity

Gross Expense Ratio:
      1.19%

    The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investment in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price, reinvested distributions, and a 5.75% maximum sales charge where indicated. Returns do not consider capital gains or income taxes on an individual's investment.

    Cumulative Returns
    • A

    Compare to Indices

    Global Opportunities Fund
    VALUE of $10,000.00

    Calendar Year Returns % (w/o sales charge)
    Data as of 9/28/16
      1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 YTD
    • B
    Global Opportunities Fund 15.00 -6.18 39.49 -4.70 17.37 15.31 28.25 12.83 86.57 -4.22 -16.32 -26.99 57.25 29.88 17.43 11.00 3.58 -41.92 75.79 12.63 -9.24 10.28 40.68 -3.46 13.93 13.63
    MSCI ACWI 20.95 11.66 -42.19 34.63 12.67 -7.35 16.13 22.80 4.16 -2.36
    Capital Gains Distributions ($ per share)
    Data as of 9/28/16
      2011 2012 2013 2014 2015
    Short Term
    Long Term 0.2496
    Total Amount of Distribution 0.2496
    Record Date 12/10/15
    Ex Div Date 12/11/15
    Pay Date 12/11/15

    There is no guarantee of the payment of any dividend or other distributions at any level.

    The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investment in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price, reinvested distributions, and a 5.75% maximum sales charge where indicated. Returns do not consider capital gains or income taxes on an individual's investment.

    Average Annual Total Returns
    • A

    as of 8/31/16

    as of 6/30/16

    • A
    YTD (as of 9/28/16)
    • B
    13.63%
    1 Year 23.73%
    3 Year 12.16%
    5 Year 11.51%
    10 Year 7.81%
    Since Inception 11.48%
    YTD (as of 9/28/16)
    • B
    13.63%
    1 Year 16.62%
    3 Year 9.97%
    5 Year 10.20%
    10 Year 7.18%
    Since Inception 11.22%
    YTD (as of 9/28/16)
    • B
    13.63%
    1 Year 5.95%
    3 Year 10.76%
    5 Year 8.16%
    10 Year 6.78%
    Since Inception 11.12%
    YTD (as of 9/28/16)
    • B
    13.63%
    1 Year -0.14%
    3 Year 8.60%
    5 Year 6.89%
    10 Year 6.14%
    Since Inception 10.86%
    Gross Expense Ratio
    1.19%
    NAV
    • C
    as of 9/28/16
    $50.94

    The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investment in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price, reinvested distributions, and a 5.75% maximum sales charge where indicated. Returns do not consider capital gains or income taxes on an individual's investment.

    "Year to Date" returns are cumulative, not annualized, and do not reflect sales charges.  These returns would be lower if sales charges were taken into consideration.  Short-term returns may not be indicative of longer-term performance, which should also be considered when making investment decisions.

    Top 20 Stock Holdings By Issuers

    (49.4% of assets) as of 8/31/16

    Nektar Therapeutics
    12.6%
    Advanced Micro Devices
    5.6%
    Fingerprint Cards AB
    2.8%
    Genmab A/S
    2.6%
    Coherent, Inc.
    2.6%
    H. Lundbeck AS
    2.2%
    Pandora AS
    2.0%
    Arcam AB
    1.8%
    Novozymes AS
    1.8%
    Seattle Genetics, Inc.
    1.7%
    M3, Inc.
    1.6%
    SuperGroup plc
    1.6%
    Tesla Motors, Inc.
    1.4%
    IP Group plc
    1.4%
    PTC, Inc.
    1.4%
    Iconix Brand Group, Inc.
    1.4%
    Cepheid
    1.3%
    Ci:z Holdings Co. Ltd.
    1.2%
    Slm Solutions Group AG
    1.2%
    Cyberagent, Inc.
    1.2%
    ×
    • 12.6 %
      Nektar Therapeutics
    • Researches and develops inhalation drug delivery systems
      Source: FactSet
    COUNTRY United States
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Pharmaceuticals
    ×
    • 5.6 %
      Advanced Micro Devices
    • Manufactures integrated circuits for semiconductors
      Source: FactSet
    COUNTRY United States
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Semiconductors & Semiconductor Equipment
    ×
    • 2.8 %
      Fingerprint Cards AB
    • Develops, produces, and markets biometric system technologies
      Source: FactSet
    COUNTRY Sweden
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Electronic Equipment Instruments & Components
    ×
    • 2.6 %
      Genmab A/S
    • Develops human antibody therapeutics for the treatment of cancer
      Source: FactSet
    COUNTRY Denmark
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Biotechnology
    ×
    • 2.6 %
      Coherent, Inc.
    • Manufactures and supplies laser diodes and other laser equipment
      Source: FactSet
    COUNTRY United States
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Electronic Equipment Instruments & Components
    ×
    • 2.2 %
      H. Lundbeck AS
    • Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases
      Source: FactSet
    COUNTRY Denmark
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Pharmaceuticals
    ×
    • 2.0 %
      Pandora AS
    • Manufactures and sells jewelry
      Source: FactSet
    COUNTRY Denmark
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Textiles Apparel & Luxury Goods
    ×
    • 1.8 %
      Arcam AB
    • Provides equipment for the direct manufactures of metal components
      Source: FactSet
    COUNTRY Sweden
    SECTOR Industrials
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Machinery
    ×
    • 1.8 %
      Novozymes AS
    • Provides biological solutions and enzyme products
      Source: FactSet
    COUNTRY Denmark
    SECTOR Materials
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Chemicals
    ×
    • 1.7 %
      Seattle Genetics, Inc.
    • Developes monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases
      Source: FactSet
    COUNTRY United States
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Biotechnology
    ×
    • 1.6 %
      M3, Inc.
    • Provides medical related services through the Internet
      Source: FactSet
    COUNTRY Japan
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Health Care Technology
    ×
    • 1.6 %
      SuperGroup plc
    • Designs and sells branded premium quality clothing and accessories for men and women
      Source: FactSet
    COUNTRY United Kingdom
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Specialty Retail
    ×
    • 1.4 %
      Tesla Motors, Inc.
    • Designs and manufactures electric sports cars
      Source: FactSet
    COUNTRY United States
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Automobiles
    ×
    • 1.4 %
      IP Group plc
    • Operates as an intellectual property commercialization company
      Source: FactSet
    COUNTRY United Kingdom
    SECTOR Financials
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Capital Markets
    ×
    • 1.4 %
      PTC, Inc.
    • Develops and provides software based product management and development solutions
      Source: FactSet
    COUNTRY United States
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Software
    ×
    • 1.4 %
      Iconix Brand Group, Inc.
    • Wholesales apparel, footwear and fashion accessories
      Source: FactSet
    COUNTRY United States
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Textiles Apparel & Luxury Goods
    ×
    • 1.3 %
      Cepheid
    • Develops, manufactures and markets fully-integrated systems that perform genetic analysis
      Source: FactSet
    COUNTRY United States
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Biotechnology
    ×
    • 1.2 %
      Ci:z Holdings Co. Ltd.
    • Engages in the manufacture and sale of cosmetics and skincare products
      Source: FactSet
    COUNTRY Japan
    SECTOR Consumer Staples
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Personal Products
    ×
    • 1.2 %
      Slm Solutions Group AG
    • Provides metal based additive manufacturing technologies
      Source: FactSet
    COUNTRY Germany
    SECTOR Industrials
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Machinery
    ×
    • 1.2 %
      Cyberagent, Inc.
    • Provides Internet advertising and media content services
      Source: FactSet
    COUNTRY Japan
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Media
    Holdings Breakdown

    as of 8/31/16

    47.0%

    United States

    13.4%

    United Kingdom

    8.6%

    Denmark

    7.6%

    Germany

    7.0%

    Japan

    4.6%

    Sweden

    3.8%

    France

    No Top Stock Holdings By Issuers
    in
    France
    1.4%

    Belgium

    No Top Stock Holdings By Issuers
    in
    Belgium
    0.8%

    Canada

    No Top Stock Holdings By Issuers
    in
    Canada
    0.5%

    Italy

    No Top Stock Holdings By Issuers
    in
    Italy
    0.5%

    Norway

    No Top Stock Holdings By Issuers
    in
    Norway
    0.4%

    Switzerland

    No Top Stock Holdings By Issuers
    in
    Switzerland
    0.3%

    Argentina

    No Top Stock Holdings By Issuers
    in
    Argentina
    0.1%

    Hong Kong

    No Top Stock Holdings By Issuers
    in
    Hong Kong
    Developed Markets 3
    Emerging Markets 3
    47.8%

    Americas

    No Top Stock Holdings By Issuers
    in
    Americas
    40.6%

    Europe

    No Top Stock Holdings By Issuers
    in
    Europe
    7.1%

    Asia Pacific

    No Top Stock Holdings By Issuers
    in
    Asia Pacific
    0.3%

    Americas

    No Top Stock Holdings By Issuers
    in
    Americas
    30.5%

    Health Care

    22.7%

    Information Technology

    21.4%

    Consumer Discretionary

    10.0%

    Industrials

    5.0%

    Financials

    4.6%

    Materials

    1.6%

    Consumer Staples

    15.6%

    Pharmaceuticals

    8.8%

    Biotechnology

    7.9%

    Semiconductors & Semiconductor Equipment

    7.8%

    Electronic Equipment Instruments & Components

    4.7%

    Internet & Catalog Retail

    No Top Stock Holdings By Issuers
    in
    Internet & Catalog Retail
    4.6%

    Chemicals

    4.2%

    Machinery

    4.0%

    Specialty Retail

    3.9%

    Capital Markets

    3.7%

    Textiles Apparel & Luxury Goods

    3.5%

    Software

    3.4%

    Media

    2.5%

    Health Care Equipment & Supplies

    No Top Stock Holdings By Issuers
    in
    Health Care Equipment & Supplies
    2.5%

    Aerospace & Defense

    No Top Stock Holdings By Issuers
    in
    Aerospace & Defense
    1.9%

    Life Sciences Tools & Services

    No Top Stock Holdings By Issuers
    in
    Life Sciences Tools & Services
    1.8%

    Hotels Restaurants & Leisure

    No Top Stock Holdings By Issuers
    in
    Hotels Restaurants & Leisure
    1.7%

    Internet Software & Services

    No Top Stock Holdings By Issuers
    in
    Internet Software & Services
    1.6%

    Health Care Technology

    1.5%

    Technology Hardware Storage & Peripherals

    No Top Stock Holdings By Issuers
    in
    Technology Hardware Storage & Peripherals
    1.5%

    Professional Services

    No Top Stock Holdings By Issuers
    in
    Professional Services
    95.8%

    4.2%

    No Top Stock Holdings By Issuers
    in
    Net Cash and Equivalents
    21.7%

    Large

    34.4%

    Mid

    43.9%

    Small

    Morningstar
    • D

    as of 8/31/16

    (based on risk adjusted performance)

    Overall Rating
    Number of Funds 942
    Category World Stock
    Risk Measurements

    as of 8/31/16

    Alpha 5.69%
    Beta 1.02
    R-Squared
    46.89
    Sharpe Ratio
    0.75
    Standard Deviation
    17.3%
    Equity Style
    • E
    Total Assets (all classes)
    as of 8/31/16
    $3.7 BN
    Portfolio Statistics

    as of 8/31/16

    Avg Market Cap (weighted) 6.5 BN
    Median Market Cap (weighted) 3.0 BN
    P/E (next 12 months) 40.26
    Price/Book Value (LTM) 4.55
    Investment Minimums
    Initial
    $1,000
    Dividends ($ per share)
    • F
    Est Frequency Annual
    Last Pay Date 12/11/15
    Per Share ($) 0.0471
    12-Month Distribution ($) 0.0471
    Distribution Sources
    Net Income 0.00%
    Net Profit from Sale 100.00%
    Other Capital Sources 0.00%
    Top 20 Stock Holdings By Issuers

    (49.4% of assets) as of 8/31/16

    Nektar Therapeu...
    12.6%
    Advanced Micro ...
    5.6%
    Fingerprint Car...
    2.8%
    Genmab A/S
    2.6%
    Coherent, Inc.
    2.6%
    H. Lundbeck AS
    2.2%
    Pandora AS
    2.0%
    Arcam AB
    1.8%
    Novozymes AS
    1.8%
    Seattle Genetic...
    1.7%
    M3, Inc.
    1.6%
    SuperGroup plc
    1.6%
    Tesla Motors, I...
    1.4%
    IP Group plc
    1.4%
    PTC, Inc.
    1.4%
    Iconix Brand Gr...
    1.4%
    Cepheid
    1.3%
    Ci:z Holdings C...
    1.2%
    Slm Solutions G...
    1.2%
    Cyberagent, Inc...
    1.2%
    Holdings Breakdown

    as of 8/31/16

    Reset
    47.0%

    United States

    13.4%

    United Kingdom

    8.6%

    Denmark

    7.6%

    Germany

    7.0%

    Japan

    4.6%

    Sweden

    3.8%

    France

    No Top Stock Holdings By Issuers
    in
    France
    1.4%

    Belgium

    No Top Stock Holdings By Issuers
    in
    Belgium
    0.8%

    Canada

    No Top Stock Holdings By Issuers
    in
    Canada
    0.5%

    Italy

    No Top Stock Holdings By Issuers
    in
    Italy
    0.5%

    Norway

    No Top Stock Holdings By Issuers
    in
    Norway
    0.4%

    Switzerland

    No Top Stock Holdings By Issuers
    in
    Switzerland
    0.3%

    Argentina

    No Top Stock Holdings By Issuers
    in
    Argentina
    0.1%

    Hong Kong

    No Top Stock Holdings By Issuers
    in
    Hong Kong
    47.8%

    Americas

    No Top Stock Holdings By Issuers
    in
    Americas
    40.6%

    Europe

    No Top Stock Holdings By Issuers
    in
    Europe
    7.1%

    Asia Pacific

    No Top Stock Holdings By Issuers
    in
    Asia Pacific
    0.3%

    Americas

    No Top Stock Holdings By Issuers
    in
    Americas
    30.5%

    Health Care

    22.7%

    Information Technology

    21.4%

    Consumer Discretionary

    10.0%

    Industrials

    5.0%

    Financials

    4.6%

    Materials

    1.6%

    Consumer Staples

    15.6%

    Pharmaceuticals

    8.8%

    Biotechnology

    7.9%

    Semiconductors & Semiconductor Equipment

    7.8%

    Electronic Equipment Instruments & Components

    4.7%

    Internet & Catalog Retail

    No Top Stock Holdings By Issuers
    in
    Internet & Catalog Retail
    4.6%

    Chemicals

    4.2%

    Machinery

    4.0%

    Specialty Retail

    3.9%

    Capital Markets

    3.7%

    Textiles Apparel & Luxury Goods

    3.5%

    Software

    3.4%

    Media

    2.5%

    Health Care Equipment & Supplies

    No Top Stock Holdings By Issuers
    in
    Health Care Equipment & Supplies
    2.5%

    Aerospace & Defense

    No Top Stock Holdings By Issuers
    in
    Aerospace & Defense
    1.9%

    Life Sciences Tools & Services

    No Top Stock Holdings By Issuers
    in
    Life Sciences Tools & Services
    1.8%

    Hotels Restaurants & Leisure

    No Top Stock Holdings By Issuers
    in
    Hotels Restaurants & Leisure
    1.7%

    Internet Software & Services

    No Top Stock Holdings By Issuers
    in
    Internet Software & Services
    1.6%

    Health Care Technology

    1.5%

    Technology Hardware Storage & Peripherals

    No Top Stock Holdings By Issuers
    in
    Technology Hardware Storage & Peripherals
    1.5%

    Professional Services

    No Top Stock Holdings By Issuers
    in
    Professional Services
    95.8%

    4.2%

    No Top Stock Holdings By Issuers
    in
    Net Cash and Equivalents
    21.7%

    Large

    34.4%

    Mid

    43.9%

    Small

    ×
    • 12.6 %
      Nektar Therapeutics
    • Researches and develops inhalation drug delivery systems
      Source: FactSet
    COUNTRY United States
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Pharmaceuticals
    ×
    • 5.6 %
      Advanced Micro Devices
    • Manufactures integrated circuits for semiconductors
      Source: FactSet
    COUNTRY United States
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Semiconductors & Semiconductor Equipment
    ×
    • 2.8 %
      Fingerprint Cards AB
    • Develops, produces, and markets biometric system technologies
      Source: FactSet
    COUNTRY Sweden
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Electronic Equipment Instruments & Components
    ×
    • 2.6 %
      Genmab A/S
    • Develops human antibody therapeutics for the treatment of cancer
      Source: FactSet
    COUNTRY Denmark
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Biotechnology
    ×
    • 2.6 %
      Coherent, Inc.
    • Manufactures and supplies laser diodes and other laser equipment
      Source: FactSet
    COUNTRY United States
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Electronic Equipment Instruments & Components
    ×
    • 2.2 %
      H. Lundbeck AS
    • Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases
      Source: FactSet
    COUNTRY Denmark
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Pharmaceuticals
    ×
    • 2.0 %
      Pandora AS
    • Manufactures and sells jewelry
      Source: FactSet
    COUNTRY Denmark
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Textiles Apparel & Luxury Goods
    ×
    • 1.8 %
      Arcam AB
    • Provides equipment for the direct manufactures of metal components
      Source: FactSet
    COUNTRY Sweden
    SECTOR Industrials
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Machinery
    ×
    • 1.8 %
      Novozymes AS
    • Provides biological solutions and enzyme products
      Source: FactSet
    COUNTRY Denmark
    SECTOR Materials
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Chemicals
    ×
    • 1.7 %
      Seattle Genetics, Inc.
    • Developes monoclonal antibody-based therapeutic products for the treatment of cancer and immunologic diseases
      Source: FactSet
    COUNTRY United States
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Biotechnology
    ×
    • 1.6 %
      M3, Inc.
    • Provides medical related services through the Internet
      Source: FactSet
    COUNTRY Japan
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Health Care Technology
    ×
    • 1.6 %
      SuperGroup plc
    • Designs and sells branded premium quality clothing and accessories for men and women
      Source: FactSet
    COUNTRY United Kingdom
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Specialty Retail
    ×
    • 1.4 %
      Tesla Motors, Inc.
    • Designs and manufactures electric sports cars
      Source: FactSet
    COUNTRY United States
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Large
    INDUSTRY Automobiles
    ×
    • 1.4 %
      IP Group plc
    • Operates as an intellectual property commercialization company
      Source: FactSet
    COUNTRY United Kingdom
    SECTOR Financials
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Capital Markets
    ×
    • 1.4 %
      PTC, Inc.
    • Develops and provides software based product management and development solutions
      Source: FactSet
    COUNTRY United States
    SECTOR Information Technology
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Software
    ×
    • 1.4 %
      Iconix Brand Group, Inc.
    • Wholesales apparel, footwear and fashion accessories
      Source: FactSet
    COUNTRY United States
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Textiles Apparel & Luxury Goods
    ×
    • 1.3 %
      Cepheid
    • Develops, manufactures and markets fully-integrated systems that perform genetic analysis
      Source: FactSet
    COUNTRY United States
    SECTOR Health Care
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Biotechnology
    ×
    • 1.2 %
      Ci:z Holdings Co. Ltd.
    • Engages in the manufacture and sale of cosmetics and skincare products
      Source: FactSet
    COUNTRY Japan
    SECTOR Consumer Staples
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Personal Products
    ×
    • 1.2 %
      Slm Solutions Group AG
    • Provides metal based additive manufacturing technologies
      Source: FactSet
    COUNTRY Germany
    SECTOR Industrials
    ASSET CLASS Equity
    MARKET CAP Small
    INDUSTRY Machinery
    ×
    • 1.2 %
      Cyberagent, Inc.
    • Provides Internet advertising and media content services
      Source: FactSet
    COUNTRY Japan
    SECTOR Consumer Discretionary
    ASSET CLASS Equity
    MARKET CAP Mid
    INDUSTRY Media

    Management

    Frank Jennings, Ph.D.

    Managed Fund since 10/95

    Investment Approach

    The portfolio manager invests opportunistically in domestic and foreign companies that appear likely to grow at a faster pace than world GDP and may benefit from four distinctive global themes that we call MANTRA®: Mass Affluence, New Technology, Restructuring and Aging. Within this framework, the portfolio manager uses rigorous, fundamental analysis to find industries with the highest probability for structural growth and companies with above average earnings potential due to unique product offerings and defensible positions. The portfolio has a barbell strategy that is designed to increase stability by dividing the portfolio between “offensive” and “defensive” stocks.

    Risk Management

    Our team limits exposure to individual companies, industries and sectors, seeking to limit volatility through company quality and diversification. Risk Management Overview

    We conduct rigorous fundamental research to identify individual companies with asymmetrical risk/return opportunities. Risk Management Overview

    At the portfolio level, our experienced investment personnel closely monitor the strategy's positioning, and the active risk resulting from our security selection process and sector allocations. We evaluate factor and style exposure, as well as the ownership and liquidity profile of each security in the portfolio. Risk Management Overview

    Our team proactively manages risk by constructing diversified portfolios across sectors, industry groups and securities. We manage, monitor and limit sector weights relative to specified benchmarks and security position sizes within each portfolio. Risk Management Overview

    Our team closely monitors position size and sector weights; we have limits on active security weights against the benchmark for each strategy we manage. Risk Management Overview

    Risk is managed at the portfolio, strategy and security levels to identify diversified sources of alpha. We mainly focus on currency, interest rates and credit. Positions are sized and monitored according to established limits. Risk Management Overview

    We focus primarily on senior loans in an effort to maintain product integrity and limit duration risk. Risk Management Overview

    The team manages risk at both a strategy and individual security level to help ensure that, when combined, they act as the ballast in an investor’s overall portfolio. Risk Management Overview

    Risk is managed at the portfolio, strategy and security levels to identify diversified sources of alpha. We seek to identify primary and secondary risks of each investment. Diversification of sectors can potentially reduce volatility. Risk Management Overview

    The team manages risk by administering duration limits, limiting portfolio weighted average maturity and conducting thorough credit analysis on individual securities. Risk Management Overview

    The Rochester team has created diverse portfolios designed to mitigate the types of risks that municipal bond investors may encounter. Risk Management Overview

    The Commodities team manages risk on multiple levels, including individual commodity sector levels and overall fund level. Risk Management Overview

    The Real Estate team monitors and manages risk at the security, sector and strategy levels. Risk Management Overview

    The Global Multi-Asset Group monitors and manages risk on an ongoing basis, both at the asset class and portfolio levels. Risk Management Overview

    We emphasize capital preservation by avoiding companies that may cut distributions. We seek to build diversified portfolios comprised of energy and energy related companies with attractive risk-adjusted total return potential. Risk Management Overview

    The Alternative Strategies team evaluates risk on multiple levels, applying numerous risk analysis methods on an ongoing basis in addition to assessing risk impacts of a position prior to making investment decisions. Risk Management Overview

    Risk is monitored by quantitative risk system and managed at many levels – stock, sector, country, and style factors. We seek to diversify the portfolio across the global listed infrastructure market and adhere to an established risk framework, including constraints imposed by position limits versus a benchmark. Risk Management Overview

    We monitor and manage both security and sector weights to the underlying index to ensure that the portfolio is properly tracking its benchmark. Also, partnering with well-known index providers ensures that we hold only high quality securities that pass very stringent profitability and liquidity screens. Risk Management Overview

    ×

    Tools

    1. 1. Special Risks: Foreign investments may be volatile and involve additional expenses and special risks, including currency fluctuations, foreign taxes, regulatory and geopolitical risks. Emerging and developing market investments may be especially volatile. Eurozone investments may be subject to volatility and liquidity issues. Investments in securities of growth companies may be volatile. Mid-sized company stock is typically more volatile than that of larger company stock. It may take a substantial period of time to realize a gain on an investment in a mid-sized company, if any gain is realized at all. Fixed income investing entails credit and interest rate risks. When interest rates rise, bond prices generally fall, and the Fund’s share prices can fall. Below-investment-grade (“high yield” or "junk") bonds are more at risk of default and are subject to liquidity risk. Diversification does not guarantee profit or protect against loss.
    2. 2. Access index definitions.
    3. 3. Holdings are subject to change, and are dollar weighted based on total net assets. Negative weightings may result from the use of leverage. Leverage involves the use of various financial instruments or borrowed capital in an attempt to increase investment return. Leverage risks include potential for higher volatility, greater decline of the fund's net asset value and fluctuations of dividends and distributions paid by the fund.
    4. 4. Holdings are subject to change, are dollar-weighted based on assets, and may not reflect the use of leverage in the Fund.
    5. A. The performance data quoted represents past performance, which does not guarantee future results. The investment return and principal value of an investment in the Fund will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Current performance and expense ratios may be lower or higher than the data quoted. Fund returns include changes in share price, reinvested distributions, and a 5.75% maximum sales charge where indicated. Returns do not consider capital gains or income taxes on an individual's investment.
    6. B. "Year to Date" returns are cumulative, not annualized, and do not reflect sales charges.  These returns would be lower if sales charges were taken into consideration.  Short-term returns may not be indicative of longer-term performance, which should also be considered when making investment decisions.
    7. C. Daily net asset value and dollar change of the fund is as of the previous business day's closing. Fund net asset values are updated at approximately 7 p.m. ET daily.
    8. D. Class A shares rated 4 stars overall by Morningstar among  942  World Stock funds for the 3-, 5-, and 10 year period ended 8/31/16 based on risk-adjusted performance.
    9. E. OppenheimerFunds' equity style box is based on the portfolio's overall targeted capitalization range and relative valuation as determined by OFI.
    10. F. There is no guarantee of the payment of any dividend or other distributions at any level.
    ×
    Loading...
    Tiny Button Small Button Large Button Default Button Secondary Button Framed Button Framed Button ( Small Caps )